Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Dec 13:11:1340377.
doi: 10.3389/fbioe.2023.1340377. eCollection 2023.

Editorial: CRISPR-aided bioengineering for value-added product development

Affiliations
Editorial

Editorial: CRISPR-aided bioengineering for value-added product development

Anindya Bandyopadhyay et al. Front Bioeng Biotechnol. .
No abstract available

Keywords: CRISPR; CRISPR methylation; CRISPRi; base editor; bioprospecting; biotechnology; computational design; gene editing.

PubMed Disclaimer

Conflict of interest statement

Author MK was employed by LanzaTech Inc. Author TM was co-founder of Moonshot Bio Inc. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Comment on

  • Editorial on the Research Topic CRISPR-aided bioengineering for value-added product development

References

    1. Bloomberg (2022). Statistics on global CRISPR genome editing market size and share to surpass USD 15.84 billion by 2028, exhibit a CAGR of 29.50% . https://www.bloomberg.com/press-releases/2022-06-22/statistics-on-global... (Available at: [Accessed November 14, 2023].
    1. Jinek M., Chylinski K., Fonfara I., Hauer M., Doudna J. A., Charpentier E. (2012). A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816–821. 10.1126/science.1225829 - DOI - PMC - PubMed
    1. Moon T. S. (2023). EBRC: enhancing bioeconomy through research and communication. N. Biotechnol. 78, 150–152. 10.1016/J.NBT.2023.10.012 - DOI - PubMed
    1. Wang J. Y., Doudna J. A. (2023). CRISPR technology: a decade of genome editing is only the beginning. Science 379, eadd8643. 10.1126/science.add8643 - DOI - PubMed
    1. Wong C. (2023). UK first to approve CRISPR treatment for diseases: what you need to know. Nature 623, 676–677. 10.1038/D41586-023-03590-6 - DOI - PubMed

Publication types

LinkOut - more resources